`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner,
`
`v.
`
`HYPERION THERAPEUTICS, INC.,
`Patent Owner.
`
`
`
`
`
`_____________________
`
`Case IPR2015-01117
`Patent 8,642,012
`_____________________
`
`ERRATA AND SIGNATURE PAGES OF
`DR. NEAL SONDHEIMER’S MARCH 10 & 11, 2016 DEPOSITIONS
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
` ERRATA SHEET
`
`235
`
` Page Line
`
` I, Neal Sondheimer, have reviewed pages 3 to
`
` 234, and with the exception of the above-noted
`
` corrections, hereby agree to the accuracy of my
`
` statement recorded herein.
`
` Date:
`
` Signature:
`
`[3/10/2016] IPR - Sondheimer, Neal (2016.03.10)
`
`1
`
`2 3 4 5 6
`
`7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`29
`
`30
`
`31
`
`32
`
`33
`
`34
`
`35
`
`36
`
`37
`
`March 20, 2016
`
`
`
` ERRATA SHEET
`
`56
`
` Page Line
`
` I, Neal Sondheimer, have reviewed pages 3 to 54,
`
` and with the exception of the above-noted corrections,
`
` hereby agree to the accuracy of my statement recorded
`
` herein.
`
` Date:
`
` Signature:
`
`[3/11/2016] IPR - Sondheimer, Neal (2016.03.11)
`
`1
`
`2 3 4 5 6
`
`7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`29
`
`30
`
`31
`
`32
`
`33
`
`34
`
`35
`
`36
`
`37
`
`March 20, 2016
`
`
`
`Reason for
`change:
`Transcription error
`Transcription error
`Transcription error
`Transcription error
`Purposes of clarity
`
`Reason for
`change:
`Transcription
`error
`typo
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`Par Pharmaceutical, Inc. v. Hyperion Therapeutics, Inc.
`Case Nos. IPR2015-01117 and IPR2015-01127
`Errata Sheet
`
`Neal Sondheimer, M.D., Ph.D.
`March 10, 2016
`
`Line
`Reads
`No.
`6,20 Phenylacetal glutamine
`17
`Proteins
`23
`674
`25
`“of developing a”
`9
`“lifted…..listed”
`
`Should be
`Phenylacetylglutamine
`Protein
`647
`“of developing”
`“listed”
`
`Deposition of:
`Date of
`Deposition:
`
`The following are the corrections that I have made to the deposition transcript:
`
`Page
`No.
`7
`77
`102
`145
`180
`
`
`
`
`
`
`Neal Sondheimer, M.D., Ph.D.
`March 11, 2016
`
`Deposition of:
`Date of
`Deposition:
`
`The following are the corrections that I have made to the deposition transcript:
`
`Page
`No.
`
`Line
`No.
`
`Reads
`
`Should be
`
`24
`32
`
`
`
`7
`7
`
`“Do you the density”
`Shi
`
`“Do you know the density”
`Shih
`
`1
`
`
`
`CERTIFICATION OF SERVICE (37 C.F.R. §§ 42.6(e), 42.105(a))
`
` IPR2015-01117
`Patent No. 8,642,012
`Certificate of Service
`
`
`The undersigned hereby certifies that the above-captioned “Errata and
`
`Signature Pages of Dr. Neal Sondheimer’s March 10 & 11, 2016 Depositions” was
`
`served in its entirety on March 28, 2016 through the Patent Review Processing
`
`System, and additionally upon the following parties via Electronic Mail:
`
`
`
`Lauren Stevens: lstevens@horizonpharma.com
`Matthew C. Phillips: matthew.phillips@renaissanceiplaw.com
`Dennis Bennett: dennisbennett@globalpatentgroup.com
`
`Robert Green: rgreen@greengriffith.com
`Emer Simic: esimic@greengriffith.com
`Jessica Tyrus: jtyrus@greengriffith.com
`
`Respectfully Submitted,
`
`
`
`Aziz Burgy
`Registration No. 51,514
`Attorney for Petitioner
`Par Pharmaceutical, Inc.
`
`
`Date: March 28, 2016
`Axinn, Veltrop & Harkrider LLP
`950 F Street, N.W.
`Washington, DC 20004
`Tel: (202) 912-4700